Lubrizol Acquires Laboratoire Phenobio

(BRK.A), (BRK.B)

The Lubrizol Corporation has announced the acquisition of Laboratoire Phenobio, an innovative supplier of naturally-derived extracts and botanical active ingredients. Recognized across the world as a pioneer in botanical extracts and natural performance ingredients, this addition expands Lubrizol’s existing capabilities to provide clean natural ingredients across the cosmetic, nutraceutical and life sciences industries.

Located near the Bordeaux region in France, the company’s unique capabilities in subcritical water extraction (SWE) of botanical biomass, coupled with their energy-economic and eco-responsible technologies provide significant value to Lubrizol’s global sustainability efforts. This expertise includes a technology used to extract phytoactives from botanical raw materials and is also commonly known as pressurized low polarity water (PLPW). The technology involves extraction of a broad range of phytoactives that are not normally obtained with only water.

“Lubrizol continues to invest in innovative technologies to offer step change formulations for the personal care and life sciences markets” states Deb Langer, Lubrizol vice president and general manager of personal, home and healthcare. “With this acquisition, Lubrizol customers will have access to novel botanical extracts compliant with ECOCERTĀ® and COSMOS standards that meet the naturality and sustainability expectations end users are requiring on a global basis. Additionally, our preferred partners will have access to final formulations using this exciting new technology.”

Ā© 2019 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell the stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.

Leave a Reply